insights_auto
Zakaj je tečaj GNLX zrasel 2,40%?
Podrobneje raziščichevron_right
GNLX:NASDAQ
Genelux Corp
2,56 $
arrow_upward
+2,40%(+0,060) 1D
9. okt., 16:00:01 GMT -4 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za GNLX …
Odpri
2,48 $
Visoka
2,57 $
Nizka
2,47 $
Tržna kapitalizacija
115,83 mio.
Povprečni promet
275,44 tis.
Promet
154,65 tis.
52-tedenski najvišji tečaj
8,54 $
52-tedenski najnižji tečaj
2,29 $
Čisti dobiček na delnico
−0,87 $
Beta
0,59
Št. izdanih delnic
45,24 mio.
Št. zaposlenih
26
Odpri
2,48 $
Visoka
2,57 $
Nizka
2,47 $
Tržna kapitalizacija
115,83 mio.
Povprečni promet
275,44 tis.
Promet
154,65 tis.
52-tedenski najvišji tečaj
8,54 $
52-tedenski najnižji tečaj
2,29 $
Čisti dobiček na delnico
−0,87 $
Beta
0,59
Št. izdanih delnic
45,24 mio.
Št. zaposlenih
26
Novice
Iz spletnih virov in novičarskih partnerjev
https://www.dars.gov.et/
·
pred 1 tednom
Genelux Corporation (GNLX) Slips 0.40% to $2.52 as Shares Hold Above Near-Term Support - Force Index
Profil
Genelux Corporation is a publicly traded late clinical-stage company developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec, is a proprietary, modified strain of the vaccinia virus, a stable DNA virus with a large engineering capacity.
The core of Genelux’s discovery and development efforts revolves around the company's proprietary CHOICE™ platform from which the Company has developed an extensive library of isolated and engineered oncolytic vaccinia virus immunotherapeutic product candidates, including Olvi-Vec.
The company is currently entered its pivot Phase 3 study in Platinum resistant/refractory ovarian cancer. Trial design based on VIRO-15 Phase 2 trial which showed independent anti-tumor activity of Olvi-Vec and reversal of platinum resistance in the TME. Wikipedia
Vizitka: Genelux Corp
Generalni direktor-
Št. zaposlenih26
Ustanovljeno2001
SedežWestlake Village, Kalifornija, Združene države Amerike
Sektor-
Spletno mestogenelux.com